Last checked at 2 Nov 2023 10:14
LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'
(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Glaxosmithkline Share News (GSK)
GSK Share
Price
GSK Share
News6
GSK Share
Chat1
GSK Share
Trades5,122
GSK
Live RNS1
GSK Share
Charts
GSK Level 2
Console
GSK Live
Share Price
GSK Broker
Ratings1
GSK Directors
Deals
GSK Financial
Diary
GSK
Fundamentals
GSK Short
Positions
GSK
Media
Glaxosmithkline Information
Share Price Information for Glaxosmithkline (GSK)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
1,708.00
Bid:
1,708.00
Ask:
1,708.50
Change:
35.00 (2.09%)
Spread:
0.50 (0.029%)
Open:
1,685.50
High:
1,712.50
Low:
1,673.00
Prev. Close:
1,673.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.FTSE 100 movers: Financials mixed as investor lock in profits
Fri, 22nd Jul 2011 14:18
The financial sector was mixed on Friday, despite rising strongly early on following yesterday's Eurozone deal to bailout Greece. Shares soared on Thursday after the region's leaders agreed a new aid package for Greece and an overhaul of the Eurozone sovereign rescue fund. While RBS bucked the trend amongst financials - with the part-nationalised bank gaining 2.36% to trade at 36.90p - other financial shares lost some of their earlier buoyancy as investors looked to lock in some profits following yesterday's gains. Lloyds and insurance peers Prudential, Old Mutual and Legal & General were prominent among the fallers.Aviva, however, rose higher after takeover rumours regarding the insurance firm resurfaced, citing two European peers (Allianz and Zurich Financial) to be potential suitors. Engineering peers IMI and Weir were among the top performers, gaining 3.48% and 1.93%, respectively.Silver mining giant Fresnillo, too, was a high riser tracking silver prices upwards. Silver futures were 2.52% up at $39.93 at 14:12 on Friday afternoon in London (09:31 in New York).Drugs giants AstraZeneca and GlaxoSmithKline fell into the red after UBS cut its rating on the European pharmaceutical sector from 'small overweight' to 'neutral', saying the defensive sector that benefited from the economic soft patch and the sovereign debt crisis will be hit by the turnaround in these lead indicators. Vodafone was firmer after reporting that revenue from its core business grew by 1.5% in the second quarter of 2011.Outsourcing giant Capita was in demand after the acquisition of the pensions administration and software business of NorthgateArinso for £27.5m.BCFTSE 100 - RisersIMI (IMI) 1,099.00p +3.48%Fresnillo (FRES) 1,687.00p +2.62%Royal Bank of Scotland Group (RBS) 36.90p +2.36%Capita Group (CPI) 700.00p +2.04%Weir Group (WEIR) 2,163.00p +1.93%Marks & Spencer Group (MKS) 360.50p +1.92%Vodafone Group (VOD) 164.25p +1.83%Vedanta Resources (VED) 1,881.00p +1.79%International Consolidated Airlines Group SA (IAG) 242.00p +1.77%WPP (WPP) 734.50p +1.66%FTSE 100 - FallersLloyds Banking Group (LLOY) 46.70p -1.82%Essar Energy (ESSR) 379.00p -1.30%Prudential (PRU) 689.50p -1.29%Old Mutual (OML) 130.00p -1.07%Legal & General Group (LGEN) 116.00p -1.02%Admiral Group (ADM) 1,572.00p -1.01%AstraZeneca (AZN) 3,061.50p -0.99%Rexam (REX) 380.70p -0.91%Investec (INVP) 503.50p -0.89%Amec (AMEC) 1,116.00p -0.80%
More News
1 Nov 2023 16:52
LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls
(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.
Read more1 Nov 2023 16:35
London close: Stocks rise ahead of US Fed policy decision
(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.
Read more1 Nov 2023 08:51
TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy
(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.
Read more1 Nov 2023 08:50
LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles
(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.
Read more1 Nov 2023 07:40
LONDON BRIEFING: GSK raises annual guidance following Arexvy launch
(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.
Read more1 Nov 2023 07:27
GSK hikes guidance after strong third quarter
(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.
Read more30 Oct 2023 09:01
IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial
GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.
Read more30 Oct 2023 07:06
GSK's Jemperli sees success in endometrial cancer trial
(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.
Read more26 Oct 2023 09:19
TOP NEWS: GSK subsidiary ViiV receives HIV drug approval in China
(Alliance News) - GSK PLC on Thursday said its subsidiary ViiV Healthcare has received marketing authorisation in China for its cabotegravir treatment, marketed as Vocabria.
Read more26 Oct 2023 07:02
GSK HIV injection regimen gets approval in China
(Sharecast News) - GSK announced on Thursday that its majority-owned HIV specialist subsidiary ViiV has received approval from the National Medical Products Administration (NMPA) of China for an injection regimen.
Read more25 Oct 2023 16:01
UK earnings, trading statements calendar - next 7 days
| Thursday 26 October | |
| Bank of Ireland Group PLC | Trading Statement |
| Bloomsbury Publishing PLC | Half Year Results |
| Botswana Diamonds PLC | Trading Statement |
| C&C Group PLC | Half Year Results |
| e-Therapeutics PLC | Half Year Results |
| Financials Acquisition Corp | Trading Statement |
| GCP Infrastructure Investments Ltd | Trading Statement |
| HarbourVest Global Private Equity Ltd | Half Year Results |
| Hummingbird Resources PLC | Trading Statement |
| Hunting PLC | Trading Statement |
| Inchcape PLC | Trading Statement |
| International Personal Finance PLC | Trading Statement |
| PPHE Hotel Group Ltd | Trading Statement |
| Renishaw PLC | Trading Statement |
| Standard Chartered PLC | Q3 Results |
| Unilever PLC | Trading Statement |
| WPP PLC | Trading Statement |
| Friday 27 October | |
| International Consolidated Airlines Group SA | Q3 Results |
| NatWest Group PLC | Q3 Results |
| Monday 30 October | |
| Airtel Africa PLC | Half Year Results |
| Computacenter PLC | Trading Statement |
| Glencore PLC | Trading Statement |
| HSBC Holdings PLC | Q3 Results |
| Lok'n Store Group PLC | Full Year Results |
| Pearson PLC | Trading Statement |
| Tuesday 31 October | |
| BP PLC | Q3 Results |
| Coca-Cola HBC AG | Trading Statement |
| Elementis PLC | Trading Statement |
| essensys PLC | Full Year Results |
| Georgia Capital PLC | Q3 Results |
| Grit Real Estate Income Group Ltd | Full Year Results |
| RHI Magnesita NV | Trading Statement |
| Spectris PLC | Q3 Results |
| TP ICAP Group PLC | Trading Statement |
| UP Global Sourcing Holdings PLC | Full Year Results |
| Wednesday 1 November | |
| Asos PLC | Full Year Results |
| Aston Martin Lagonda Global Holdings PLC | Q3 Results |
| Beximco Pharmaceuticals Ltd | Full Year Results |
| GSK PLC | Q3 Results |
| Next PLC | Trading Statement |
| Smurfit Kappa Group PLC | Trading Statement |
| Weir Group PLC | Trading Statement |
| Copyright 2023 Alliance News Ltd. All Rights Reserved. | |
25 Oct 2023 09:35
GSK says RSV jab shows promising response in adults aged 50 to 59
(Alliance News) - GSK PLC on Wednesday said a trial found its respiratory syncytial virus vaccine Arexy delivered an immune response in adults aged 50 to 59.
Read more25 Oct 2023 07:27
GSK hails success in US RSV vaccine trial
(Sharecast News) - Pharma giant GSK has announced positive preliminary results from a trial of its Arexvy vaccine to treatment respiratory syncytial virus (RSV) disease for a younger patient population in the US.
Read more16 Oct 2023 08:09
TOP NEWS: GSK receives positive EU opinion on Jemperli for cancer
(Alliance News) - GSK PLC on Monday said its monoclonal antibody Jemperli is closer to becoming the first new frontline treatment option in the EU in decades for a certain form of endometrial cancer.
Read more